health
Gout Flare
Adverse effectA gout flare is an acute attack of gout, representing a harmful health outcome rather than simply a change in a laboratory measurement. It may be relevant when an intervention increases serum uric acid, because that increase can potentially trigger an attack in people predisposed to gout.
Gout Flare is listed as a health effect for focused reference.
These are research findings, not promises. Most options have little evidence, and results differ from person to person.
What can cause it
How likely each one is to cause it, most likely first.
FastingpracticeUnclear
Based on one study.
A pharmacology reference explains that fasting can raise serum uric acid because ketones compete with urate for renal excretion; this may trigger flares in susceptible people, especially during prolonged fasts or refeeding.
Open the Fasting page
The expert view shows every study, dose protocol and source.
What can cause it
Interventions reported to bring this on1 listedHighest probability
- →PracticesFastingCertaintyLowSourceReference knowledge1 other source
A pharmacology reference explains that fasting can raise serum uric acid because ketones compete with urate for renal excretion; this may trigger flares in susceptible people, especially during prolonged fasts or refeeding.
Open FastingStudy result
Fasting raises serum uric acid as ketones compete with urate renal excretion, which can trigger gout flares in susceptible people, especially during prolonged fasts or refeeding.
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
A gout flare is an acute attack of gout, representing a harmful health outcome rather than simply a change in a laboratory measurement. It may be relevant when an intervention increases serum uric acid, because that increase can potentially trigger an attack in people predisposed to gout. Vitamin B3 (Niacin), Omega-3, Shilajit, and Creatine are listed in relation to this outcome.
How interventions help
For gout flare, the main pattern is a potential increase in serum uric acid, which may trigger an attack in people who are predisposed. This concern applies most clearly to interventions described as capable of raising uric acid, rather than to every supplement in the same way.
Vitamin B3 (Niacin) is associated with a 10-20% increase in serum uric acid. Shilajit may also raise uric acid, creating a similar potential pathway to an acute flare. These concerns are relevant to people already susceptible to gout, while the information does not specify a particular health status beyond that.
Omega-3 differs by dose and product context: a small excess of gout was observed with 4 g/day prescription icosapent ethyl, but this signal is not established for ordinary dietary omega-3 doses. Creatine has only an anecdotal mention in relation to this outcome, so it provides much less basis for drawing conclusions than a finding involving a change in uric acid. No duration, onset, or persistence after stopping is specified for these observations.
Choosing guidance
For someone with gout or a predisposition to gout attacks, the key distinction is whether an option has a plausible link to increased uric acid and how directly that link is supported. Vitamin B3 (Niacin) warrants particular caution because the cited reference describes a measurable rise in serum uric acid that may trigger attacks in predisposed individuals. Shilajit also has a potential uric-acid connection, while the concern associated with Omega-3 is not established for ordinary dietary use. Creatine is supported here only by anecdotal reporting, so its listing does not establish that it causes gout flares.
The evidence should be interpreted conservatively. The references do not specify a defined human health population, and they do not establish how quickly any effect might appear or how long exposure would need to continue. They also do not provide a basis for choosing an option by dose or treatment duration. The Omega-3 signal involves a prescription preparation and should not automatically be generalized to every Omega-3 product.
If avoiding any plausible gout trigger is the priority, options associated with a possible uric-acid increase are less suitable for people who are predisposed. A clinician or pharmacist can help interpret these distinctions alongside an individual’s gout history, current treatment, and the specific product being considered.